» Articles » PMID: 10646903

Breast Cancer Incidence Highest in the Range of One Species of House Mouse, Mus Domesticus

Overview
Journal Br J Cancer
Specialty Oncology
Date 2000 Jan 26
PMID 10646903
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Incidence of human breast cancer (HBC) varies geographically, but to date no environmental factor has explained this variation. Previously, we reported a 44% reduction in the incidence of breast cancer in women fully immunosuppressed following organ transplantation (Stewart et al (1995) Lancet 346: 796-798). In mice infected with the mouse mammary tumour virus (MMTV), immunosuppression also reduces the incidence of mammary tumours. DNA with 95% identity to MMTV is detected in 40% of human breast tumours (Wang et al (1995) Cancer Res 55: 5173-5179). These findings led us to ask whether the incidence of HBC could be correlated with the natural ranges of different species of wild mice. We found that the highest incidence of HBC worldwide occurs in lands where Mus domesticus is the resident native or introduced species of house mouse. Given the similar responses of humans and mice to immunosuppression, the near identity between human and mouse MTV DNA sequences, and the close association between HBC incidence and mouse ranges, we propose that humans acquire MMTV from mice. This zoonotic theory for a mouse-viral cause of HBC allows testable predictions and has potential importance in prevention.

Citing Articles

The viral origins of breast cancer.

Lawson J, Glenn W Infect Agent Cancer. 2024; 19(1):39.

PMID: 39187871 PMC: 11346025. DOI: 10.1186/s13027-024-00595-2.


The association between infectious agents and breast cancer: a review of the epidemiologic evidence.

Brantley K, Tamimi R Breast Cancer Res Treat. 2024; 207(2):235-252.

PMID: 38971906 DOI: 10.1007/s10549-024-07388-6.


The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature.

Rossi C, Inzani F, Cesari S, Rizzo G, Paulli M, Pedrazzoli P Pathogens. 2024; 13(6).

PMID: 38921749 PMC: 11206847. DOI: 10.3390/pathogens13060451.


Peptide Vaccines as Therapeutic and Prophylactic Agents for Female-Specific Cancers: The Current Landscape.

Lekshmy M, Dhanya C, Smrithi J, Sindhurani J, Vandanamthadathil J, Veettil J Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513965 PMC: 10383774. DOI: 10.3390/ph16071054.


The Impact of Human Mammary Tumor Virus (HMTV) on the Expression of Epidermal Growth Factor Receptor (EGFR) and Death-Domain Associated Protein (DAXX) in Breast Carcinoma Tissues.

Ali Naeem H, Nazar Ibraheim W, Abdullah Alomar S Arch Razi Inst. 2023; 78(2):689-699.

PMID: 37396746 PMC: 10314243. DOI: 10.22092/ARI.2022.359520.2440.


References
1.
Holder Jr W, Peer G, Bolognesi D, Wells Jr S . Antibody reacting with mouse mammary tumor virus in serum of breast carcinoma patients. Surg Forum. 1976; 27(62):102-4. View

2.
Bui T, Rankin J, Smith K, Huguet E, Ruben S, Strachan T . A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene. 1997; 14(10):1249-53. DOI: 10.1038/sj.onc.1200936. View

3.
Doolittle R, Feng D, Johnson M, McClure M . Origins and evolutionary relationships of retroviruses. Q Rev Biol. 1989; 64(1):1-30. DOI: 10.1086/416128. View

4.
Mills J, Childs J . Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis. 1998; 4(4):529-37. PMC: 2640244. DOI: 10.3201/eid0404.980403. View

5.
Howard D, Schlom J . Isolation of a series of novel variants of murine mammary tumor viruses with broadened host ranges. Int J Cancer. 1980; 25(5):647-54. DOI: 10.1002/ijc.2910250515. View